Effects of intravenous metamizole on ongoing and evoked activity of dura-sensitive thalamic neurons in rats

• Published in: European journal of pharmacology 2014-05, Vol.731, p.58-64
• Main Authors: Sokolov, Alexey Y., Lyubashina, Olga A., Sivachenko, Ivan B., Panteleev, Sergey S.
• Format: Article
• Language: English
• Subjects: Administration, Intravenous; Animals; Dipyrone - administration & dosage; Dipyrone - pharmacology; Dura Mater - physiology; Electric Stimulation; Male; Metamizole; Migraine; Neuronal activity; Neurons - cytology; Neurons - drug effects; Nociception - drug effects; Rats; Rats, Wistar; Tension-type headache; Thalamus; Thalamus - cytology; Thalamus - physiology; Trigemino-vascular system
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/j.ejphar.2014.03.006

Migraine and tension-type headache (TTH) are the most common forms of primary headaches. A general key mechanism underlying development of both the diseases is the trigeminal system activation associated with the ascending nociceptive transmission via the trigemino-thalamo-cortical pathway. The ventroposteromedial (VPM) nucleus is a key thalamic structure, receiving afferent inflow from the craniofacial region; it holds the third-order neurons responsible for conveying sensory information from the extra- and intracranial nociceptors to the cortex. The VPM is currently seen as a therapeutic target for various antimigraine medications, which is shown to reduce the VPM neuronal excitability. A non-opioid analgesic metamizole is widely used in some countries for acute treatment of migraine or TTH. However, the precise mechanisms underlying anticephalgic action of metamizole remain unclear. The objective of our study performed in the rat model of trigemino-durovascular nociception was to evaluate the effects of intravenously administered metamizole on ongoing and evoked firing of the dura-sensitive VPM neurons. The experiments were carried out on rats under urethane–chloralose anesthesia. Cumulative administration of metamizole (thrice-repeated intravenous infusion of 150mg/kg performed 30min apart) in 56% of cases produced a suppression of both the ongoing activity of the thalamic VPM neurons and their responses to dural electrical stimulation. Although the inhibitory effect was prevailing, a number of VPM neurons were indifferent to the administration of metamizole. These data suggest that one of the main components of neural mechanism underlying anticephalgic action of metamizole is suppression of the thalamo-cortical nociceptive transmission associated with trigemino-vascular activation.